Puma Biotechnology, Inc.
PBYINASDAQHealthcare● Active
$6.85
$-0.18(-2.56%)
Market Cap$348661274
P/E Ratio—
52W High$7.9
52W Low$3.03
Puma Biotechnology, Inc.（PBYI）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PBYI · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.23B | $0.23B | $0.24B | $0.23B | $0.25B |
| Cost of Revenue | $0.06B | $0.06B | $0.06B | $0.06B | $0.06B |
| Gross Profit | $0.17B | $0.17B | $0.17B | $0.17B | $0.19B |
| Gross Margin %(computed) | 74.53% | 72.06% | 73.40% | 75.84% | 74.84% |
| Operating Expenses | |||||
| R&D Expenses | $0.06B | $0.05B | $0.05B | $0.05B | $0.07B |
| G&A Expenses | $0.07B | $0.08B | $0.09B | $0.09B | $0.12B |
| Total Operating Expenses | $0.13B | $0.14B | $0.14B | $0.15B | $0.19B |
| Operating Income | $0.04B | $0.03B | $0.03B | $0.02B | $0.00B |
| Operating Margin %(computed) | 16.33% | 13.44% | 13.85% | 10.40% | 0.51% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | $0.04B | $0.02B | $0.02B | $0.00B | ($0.03B) |
| Income Tax Expense | $0.00B | ($0.01B) | $0.00B | $0.00B | $0.00B |
| Net Income | $0.03B | $0.03B | $0.02B | $0.00B | ($0.03B) |
| Net Margin %(computed) | 13.62% | 13.14% | 9.16% | 0.00% | -11.51% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.62 | $0.62 | $0.46 | $0.02 | $-0.72 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.04B | 0.04B |
| EBITDA | $0.05B | $0.05B | $0.05B | $0.02B | ($0.00B) |
| EBITDA Margin %(computed) | 23.36% | 20.86% | 20.17% | 9.60% | -1.85% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Puma Biotechnology, Inc.
关于Puma Biotechnology, Inc.（PBYI）损益表
Puma Biotechnology, Inc.（PBYI）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，PBYI实现营收$0.23B，毛利润$0.17B（毛利率74.53%），净利润$0.03B（净利率13.62%）。
常见问题
PBYI · 4 问Puma Biotechnology, Inc.（PBYI）2025财年营收为$0.23B，同比down0.9%。
PBYI revenuePBYI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09